HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4+ T cells

Virus Research

Volumn 132, Issue 1-2, 2008, Pages 25-32

  Poiesi, Claudio ^a   De Francesco, Maria A ^a   Baronio, Manuela ^b   Manca, Nino ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b S Orsola Hospital   (Italy)

Author keywords

Heparan sulfate; Heparin; HIV 1; Matrix protein; p17; Proteoglycan

Indexed keywords

CD4 ANTIGEN; CHLORATE; CHONDROITIN 4 SULFATE; DEXTRAN SULFATE; HEPARAN SULFATE BINDING PROTEIN; HEPARIN; PROTEIN P17; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INFLAMMATION; LIGAND BINDING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SULFATION; T LYMPHOCYTE ACTIVATION;

CD4-POSITIVE T-LYMPHOCYTES; CHLORATES; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GLYCOSAMINOGLYCANS; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HIV ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL; PROTEIN BINDING;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 38949104363     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.10.006     Document Type: Article

References (34)

1. Bernfield M., Kokenyesi R., Kato M., Hinkes M.T., Spring J., Gallo R.L., and Lose E.J. Biology of syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8 (1992) 365-393
2. Bryant M., and Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 523-527
3. Cardin A.D., and Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9 (1989) 21-32
4. Clarke D., Katoh O., Gibbs R.V., Griffiths S.D., and Gordon M.Y. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance. Cytokine 7 (1995) 325-330
5. Clasper S., Vekemans S., Fiore M., Plebanski M., Wordsworth P., David G., and Jackson D.G. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor. J. Biol. Chem. 274 (1999) 24113-24123
6. De Francesco M.A., Baronio M., Fiorentini S., Signorini C., Bonfanti C., Poiesi C., Popovic M., Grassi M., Garrafa E., Bozzo L., Lewis G.K., Licenziati S., Gallo R.C., and Caruso A. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9972-9997
7. De Francesco M.A., Caruso A., Fallacara F., Canaris A.D., Dima F., Poiesi C., Licenziati S., Corulli M., Martinelli F., Fiorentini S., and Turano A. HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor. AIDS 12 (1998) 245-252
8. De Francesco M.A., Poiesi C., Ricotta D., and Manca N. HIV p17 reverses the anti-inflammatory activity of IL-4 on IL-15 stimulated monocytes and modulates their ability to secrete MIP-1 alpha. Virus Res. 118 (2006) 170-177
9. Faham S., Hileman R.E., Fromm J.R., Linhardt R.J., and Rees D.C. Heparin structure and interactions with basic fibroblast growth factor. Science 271 (1996) 1116-1120
10. Fernandez-Botran R., Yan J., and Justus D.E. Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity. Cytokine 11 (1999) 313-325
11. Freed E.O. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251 (1998) 1-15
12. Hasan M., Najjam S., Gordon M.Y., Gibbs R.V., and Rider C.C. IL-12 is a heparin-binding cytokine. J. Immunol. 162 (1999) 1064-1070
13. Hoogewerf A.J., Cisar L.A., Evans D.C., and Bensadoun A. Effect of chlorate on the sulfation of lipoprotein lipase and heparan sulfate proteoglycans. Sulfation of heparan sulfate proteoglycans affects lipoprotein lipase degradation. J. Biol. Chem. 266 (1991) 16564-16571
14. Humphries D.E., and Silbert J.E. Chlorate: a reversible inhibitor of proteoglycan sulfatation. Biochem. Biophys. Res. Commun. 154 (1988) 365-371
15. Ibrahim J., Griffin P., Coombe D.R., Rider C.C., and James W. Cell-surface heparan sulfate facilitates human immunodeficiency virus type 1 entry into some cell lines but not primary lymphocytes. Virus Res. 60 (1999) 159-169
16. Jones K.S., Fugo K., Petrow-Sadowski C., Huang Y., Bertolette D.C., Lisinski I., Cushman S.W., Jacobson S., and Ruscetti F.W. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J. Virol. 80 (2006) 8291-8302
17. Jones K.S., Petrow-Sadowski C., Bertolette D.C., Huang Y., and Ruscett F.W. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J. Virol. 79 (2005) 12692-12702
18. Kjellen L., and Lindahl U. Proteoglycans structures and interactions. Annu. Rev. Biochem. 60 (1991) 443-475
19. Liu J., and Thorp S.C. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 22 (2002) 1-25
20. Mahoney D.J., Whittle J.D., Milner C.M., Clark S.J., Mulloy B., Buttle D.J., Jones G.C., Day A.J., and Short R.D. A method for the non-covalent immobilization of heparin to surfaces. Anal. Biochem. 330 (2004) 123-129
21. McCaffrey T.A., Falcone D.J., and Du B. Transforming growth factor-beta 1 is a heparin binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1. J. Cell. Physiol. 152 (1992) 430-440
22. Moulard M., Lortat-Jacob H., Mondor I., Roca G., Wyatt R., Sodroski J., Zhao L., Olson W., Kwong P.D., and Sattentau Q.J. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74 (2000) 1948-1960
23. Najjam S., Mulloy B., Theze J., Gordon M., Gibbs R., and Rider C.C. Further characterization of the binding of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach. Glycobiology 8 (1998) 509-516
24. Poli G., and Fauci A. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res. Hum. Retroviruses 8 (1992) 191-197
25. Poli G., Kinter A., Justement J.S., Kerl J.H., Gressler P., Stanley S., and Fauci A.S. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 782-785
26. Popovic M., Tenner-Racz K., Pelser C., Stellbrink H.J., van Lunzen J., Lewis G., Kalyanaraman V.S., Gallo R.C., and Racz P. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 14807-14812
27. Saidi H., Magri G., Carbonneil C., Nasreddine N., Requena M., and Belec L. IFN-{gamma}-activated monocytes weakly produce HIV-1 but induce the recruitment of HIV-sensitive T cells and enhance the viral production by these recruited T cells. J. Leukoc. Biol. 81 (2007) 642-653
28. Salek-Ardakani S., Arrand J.R., Shaw D., and Mackett M. Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 96 (2000) 1879-1888
29. Spillmann D. Heparan sulfate: anchor for viral intruders?. Biochimie 83 (2001) 811-817
30. Spillmann D., Witt D., and Lindahl U. Defining the interleukin-8-binding domain of heparan sulfate. J. Biol. Chem. 273 (1998) 15487-15493
31. Summerford C., and Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72 (1998) 1438-1445
32. Tiwari V., Clement C., Duncan M.B., Chen J., Liu J., and Shukla D. A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1. J. Gen. Virol. 85 (2004) 805-809
33. Tyagi M., Rusnati M., Presta M., and Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276 (2001) 3254-3261
34. Vitale M., Caruso A., De Francesco M.A., Rodella L., Bozzo L., Garrafa E., Grassi M., Gobbi G., Cacchioni A., and Fiorentini S. HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines. Br. J. Haematol. 120 (2003) 337-343